Literature DB >> 511335

Pharmacokinetics of tobramycin in the newborn.

H Yoshioka, M Takimoto, K Fujita, S Maruyama.   

Abstract

Following an intramuscular dose of 5.0 mg of tobramycin in eight full-term newborn infants, peak levels averaging 2.69 +/- 0.70 microgram/ml were attained after 30 to 60 minutes. The serum half-life thereafter correlated inversely to postnatal age during the first seven days after birth. Pharmacokinetic analysis revealed that in newborn infants the elimination rate was markedly declined, but the absorption rate was nearly the same as that in older children. Average urinary recovery within eight hours was as low as 26.8%, which suggested accumulation of this antibiotic in the renal tissue.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 511335     DOI: 10.1007/bf01640938

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  7 in total

1.  [Antibiotics in newborns and young infants].

Authors:  C Simon
Journal:  Monatsschr Kinderheilkd       Date:  1975-01

2.  Clinical pharmacology of tobramycin in newborns.

Authors:  J M Kaplan; G H McCracken; M L Thomas; L J Horton; N Davis
Journal:  Am J Dis Child       Date:  1973-05

3.  Tobramycin in the neonatal period.

Authors:  M M Kannan; H P Dalton; M R Escobar
Journal:  Va Med Mon (1918)       Date:  1973-11

4.  Renal parenchymal accumulation of aminoglycoside antibiotics in rats.

Authors:  F C Luft; S A Kleit
Journal:  J Infect Dis       Date:  1974-12       Impact factor: 5.226

5.  Simplified, accurate method for antibiotic assay of clinical specimens.

Authors:  J V Bennett; J L Brodie; E J Benner; W M Kirby
Journal:  Appl Microbiol       Date:  1966-03

6.  Gentamicin resistance in strains of Pseudomonas aeruginosa mediated by enzymatic N-acetylation of the deoxystreptamine moiety.

Authors:  M Brzezinska; R Benveniste; J Davies; P J Daniels; J Weinstein
Journal:  Biochemistry       Date:  1972-02-29       Impact factor: 3.162

7.  Comparative activity of tobramycin and gentamicin against Pseudomonas, Proteus and Providencia species.

Authors:  I B Ducan; J L Penner
Journal:  Can Med Assoc J       Date:  1975-07-12       Impact factor: 8.262

  7 in total
  3 in total

Review 1.  Clinical pharmacokinetics of aminoglycosides in the neonate: a review.

Authors:  Gian Maria Pacifici
Journal:  Eur J Clin Pharmacol       Date:  2008-12-23       Impact factor: 2.953

Review 2.  Clinical Pharmacokinetics of Penicillins, Cephalosporins and Aminoglycosides in the Neonate: A Review.

Authors:  Gian Maria Pacifici
Journal:  Pharmaceuticals (Basel)       Date:  2010-08-12

Review 3.  Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug-Resistant Bacteria.

Authors:  Christopher A Darlow; Renata M A da Costa; Sally Ellis; François Franceschi; Mike Sharland; Laura Piddock; Shampa Das; William Hope
Journal:  Paediatr Drugs       Date:  2021-08-26       Impact factor: 3.022

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.